RBC Mass, Autonomic Nervous System Integrity & Syncope Susceptibility in Chronic Fatigue Syndrome
Barry Hurwitz, Ph.D., Principle Investigator
The pathogenesis of the chronic fatigue syndrome (CFS) includes severe and debilitating fatigue, orthostatic intolerance, and the disruption of hematological, autonomic, and cardiovascular function. Our preliminary findings suggest that: 1) reduced red blood cell (RBC) mass is a critical hematological marker of CFS; and 2) RBC mass expansion improves orthostatic tolerance and fatigue beyond that ascribed to plasma volume expansion alone. However, the physiological mechanisms underlying the RBC mass treatment effect and the relationship of such mechanisms to individual differences in treatment response have not been elucidated. This proposed 5-year study will screen 150 CDC-defined CFS men and women and classify them into low and normal RBC mass groups. The CFS subjects (90 of 105 enrolled) will be studied before and after a 3-month intervention in a randomized, double-blind, placebo-controlled study of pharmaco-therapy to expand RBC mass; specifically, two CFS groups with low RBC mass (RBC-treated and placebo-treated) will be compared to another CFS group with normal RBC mass (standard and usual care). To assess whether the diminished cardiac function, characteristic of CFS orthostatic intolerance, is a consequence of myocardial origin, echocardiographic evaluation of left ventricular structure and function (left ventricular mass and wall thickness, compliance, and contractility) will be performed. In addition, autonomic integrity will be assessed during a standardized battery of tests (supine rest, paced respiration, Valsalva maneuver, lying-to standing, and sustained handgrip); baroreceptor sensitivity and a- and b-adrenoceptor sensitivity will be tested using adrenoceptor pharmacological challenge (phenylephrine, isoproterenol). To determine orthostatic susceptibility, a 70° head-up tilt (HUT) test combined with b-adrenergic agonist infusion at 2 mg/min (and then again at 5 mg/min, if the previous HUT failed to induce orthostatic hypotension) will be performed. We will further examine the treatment effect on exertional fatigue and hemodynamic and autonomic physiological response to the HUT tests. Finally, the relation between the criterion (orthostatic hypotension susceptibility) and the predictors (hemodynamic, autonomic, cardiac structure/function and baroreceptor, a-adrenoceptor and b-adrenoceptor sensitivities) will be evaluated to determine the extent to which the predictors are mediating the treatment effects on orthostatic hypotension susceptibility.
To check for eligibility, download and open the interview form.
For more information, download the brochure.
Both require Adobe Acrobat Reader
Please forward all e-mails to alexgonzalez@miami.edu
BMRC Home |
Psychology Home |
UM Home |
UM Directory
University of Miami, Behavioral Medicine Research Program
Coral Gables Campus
Behavioral Medicine Research Building
1251 Stanford Drive, Coral Gables, FL 33124
Medical Campus
Behavioral Medicine Research Center
200 BMRC, c/o VA Medical Center, 1201 NW 16th Street, Miami, FL, 33125
Comments: support@mail.psy.miami.edu